3-Hydroxycyclohexanecarboxylic acid, 95.0%, 250mg

3-(TRIFLUOROMETHYL)OXOLAN-3-OL, 95.0%, 1g

Methyl 2-amino-1H-benzo[d]imidazole-4-carboxylate, 95.0%, 5g

4,4'-Dibutoxybiphenyl>98.0%(GC)25g

4-(4-Methylpiperazin-1-yl)-2-(4-methylpiperidin-1-yl)aniline, 95%, 250mg

4-Methyl-N-(4-(phenylamino)phenyl)benzenesulfonamide, 98%, 25g

3',4',5'-Trifluoro-[1,1'-biphenyl]-2-amine, 95.0%, 5g

1-(6-Bromo-1h-indol-3-yl)ethan-1-one, 95%, 5g

Sodium pivalate hydrate, 98.0%, 100g

4-(1-Fmoc-Piperidin-4-yl)-butyric acid, 97.0%, 100mg

(S)-3,3'-Diiodo-2,2'-bis(methoxymethoxy)-1,1'-binaphthalene, ��98.0%, 5g

Ethyl 4-Hydroxybenzoate [for Biochemical Research]>99.0%(GC)(T)25g

Mandatory signs in accordance with ISO 7010, Foot protection mandatory, 100 mm, 1 piece